Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects

Exclusion Criteria

• •HbA1c ≥ 8% at Screening.
• •Use of other investigational drugs within 30 days of screening or foreseen use during the study.
• •Inability to comply with study requirements as judged by the Investigator.
• •Pregnant and/or breastfeeding.
• •Any disease or condition (medical or surgical) which, in the opinion of the investigator, might compromise the hematologic, cardiovascular, pulmonary, renal, gastrointestinal, hepatic, or central nervous system; or other conditions that may interfere with the absorption, distribution, metabolism or excretion of study drug, or would place the subject at increased risk.